香雪製藥(300147.SZ):香雪抗病毒口服液具有清熱祛濕,涼血解毒功效
格隆匯6月26日丨香雪製藥(300147.SZ)在投資者互動平台表示,公司中成藥主要產品有抗病毒口服液、橘紅系列(痰咳口服液、顆粒、煎膏、梨膏)、板藍根顆粒等。公司香雪抗病毒口服液具有清熱祛濕,涼血解毒功效,臨牀上廣泛用於治療感冒、流感、上呼吸道感染、腮腺炎、病毒性結膜炎、手足口病等疾患。公司橘紅痰咳液重用嶺南道地名貴中藥材“化橘紅”,並加以苦杏仁、白前、蜜百部、五味子化裁而成,是“温化寒痰”、“燥濕化痰”的代表方劑,可用於痰濁阻肺所致的咳嗽、氣喘、痰多、感冒、支氣管炎等症狀。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.